J. Frelinger

J. Frelinger, Denise Skrombolas, Karli Norville, 2022, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.

A. McAdam, J. Frelinger, A. Gaspari, 1995, Cellular immunology.

Clonotypic Antibodies which Stimulate T Cell Clone Proliferation

A. Sing, C. Fathman, J. Frelinger, 1984, Immunological reviews.

Multiple functional sites on a single Ia molecule defined using T cell clones and antibodies with chain-determined specificity

C. Fathman, J. Frelinger, M. Pierres, 1984, The Journal of experimental medicine.

Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells.

K. Cerosaletti, D. Bahler, J. Frelinger, 1988, Journal of immunology.

Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens.

D. Bahler, J. Frelinger, C. Landon, 1988, Journal of immunology.

Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.

L. Harwell, D. Bahler, J. Frelinger, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Mouse epidermal Ia molecules have a bone marrow origin

L. Hood, J. Frelinger, J. Frelinger, 1979, Nature.

Thy 1+ dendritic epidermal cells but not Langerhans cells express Ly 48.

J. Frelinger, A. Gaspari, B. Ferbel, 1993, The Journal of investigative dermatology.

IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.

N. Shastri, A. McAdam, J. Frelinger, 1998, Journal of immunology.

T Lymphocytes Generation of Primary Tumor-Specific Cytolytic Major Histocompatibility Antigen and Particulate Antigen in Association with Class I IL-3 Enhances Both Presentation of Exogenous

N. Shastri, A. McAdam, J. Frelinger, 1998 .

IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-γ–Dependent Mechanisms

S. Gerber, J. Frelinger, E. W. Sorensen, 2010, The Journal of Immunology.

IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-γ–Dependent Mechanisms

S. Gerber, J. Frelinger, E. W. Sorensen, 2010, The Journal of Immunology.

Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes

R. Barth, A. McAdam, J. Frelinger, 1996, Cancer Immunology, Immunotherapy.

Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.

H. Federoff, S. Dewhurst, W. Bowers, 2007, Vaccine.

Alteration of tumour response to radiation by interleukin-2 gene transfer

B. Fenton, C. Koch, P. Keng, 2000, British Journal of Cancer.

Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.

N. Shastri, D. Penney, J. Frelinger, 1996, Proceedings of the National Academy of Sciences of the United States of America.

An analysis of monoclonal T cell and antibody recognition sites on Ia molecules.

C. Fathman, J. Frelinger, M. Shigeta, 1985, The Journal of investigative dermatology.

Synergistic effects of co‐expression of the Th1 cytokines il‐2 and IFNγ on generation of murine tumor‐reactive cytotoxic cells

A. McAdam, S. Harkins, J. Frelinger, 1995, International Journal of Cancer.

Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy

K. Odunsi, J. Skitzki, A. Luster, 2016, Oncoimmunology.

Isolation and Characterization of I Region Genes from the Major Histocompatibility Complex of the Mouse

L. Hood, B. Mach, A. Winoto, 1983 .

Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes.

R. Barth, J. Frelinger, E. Lord, 1998, International journal of molecular medicine.

Peptide map comparisons of epidermal and spleen H-2 molecules

L. Hood, J. Frelinger, J. Frelinger, 1981, Immunogenetics.

CD4‐class II major histocompatibility complex interaction does not enhance killing by a class I‐restricted CD4+CD8+ cytotoxic T cell clone

A. McAdam, J. Frelinger, E. Lord, 1992, European journal of immunology.

Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo.

C. Malboeuf, S. Dewhurst, H. Lankes, 2007, Vaccine.

Tumours can act as adjuvants for humoral immunity

D. Brown, J. Frelinger, E. Lord, 2001, Immunology.

Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9.

J. Frelinger, M. Sullivan, Denise Skrombolas, 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Three cDNA clones encoding mouse transplantation antigens: Homology to immunoglobulin genes

L. Hood, T. Hunkapiller, S. Weissman, 1981, Cell.

Identification and characterization of a mouse cell surface antigen with alternative molecular forms

J. Frelinger, A. Infante, C. Baecher, 2004, Immunogenetics.

A pseudogene homologous to mouse transplantation antigens: Transplantation antigens are encoded by eight exons that correlate with protein domains

L. Hood, J. Frelinger, E. Boyse, 1981, Cell.

In Vivo Study of T-Cell Responses to Skin Alloantigens in Xenopus Using a Novel Whole-Mount Immunohistology Method

J. Robert, J. Frelinger, E. Lord, 2007, Transplantation.

Transfection of the genes for interleukin‐12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity

S. Gerber, J. Frelinger, E. Lord, 2003, International journal of cancer.

Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts

E M Lord, J. Frelinger, B. Fenton, 2003, British Journal of Cancer.

Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.

R. Barth, J. Frelinger, R. Looney, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy

J. Frelinger, Denise Skrombolas, 2014, Expert review of clinical immunology.

Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor1

Robert C. Rose, Scott A. Gerber, S. Gerber, 2005, The Journal of Immunology.

Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectors.

T. Foster, H. Federoff, S. Dewhurst, 2007, Human gene therapy.

A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.

J. Frelinger, M. Dziejman, T. Kawula, 2011, Journal of immunological methods.

Transfection of Transforming Growth Factor-β Producing Tumor EMT6 with Interleukin‐2 Elicits Tumor Rejection and Tumor Reactive Cytotoxic T‐Lymphocytes

J. Frelinger, E. Lord, M. Woods, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

T-lymphocyte clones.

C. Fathman, J. Frelinger, 1983, Annual review of immunology.

Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism.

A. McAdam, J. Frelinger, E. Lord, 1993, Cancer research.

Anti-CD43 Inhibition of T Cell Homing

E. Butcher, J. Frelinger, L. Mcevoy, 1997, The Journal of experimental medicine.

Coexpression of IL-2 and gamma-IFN enhances tumor immunity.

A. McAdam, S. Harkins, J. Frelinger, 1993, Annals of the New York Academy of Sciences.

Bone marrow origin of Ia molecules purified from epidermal cells.

J. Frelinger, J. Frelinger, 1980, The Journal of investigative dermatology.

Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16.

M. Mattei, A. Pallant, M. Fukuda, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice.

D. F. Howard, H. Federoff, W. Bowers, 2001, Human gene therapy.

Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor.

A. McAdam, J. Frelinger, E. Lord, 1995, Cellular immunology.

Analyses of RT1 products using two-dimensional polyacrylamide gels.

J. Frelinger, P. Wettstein, L. Hood, 1981, Transplantation proceedings.

Epidermal Ia molecules from theI-A andI-EC subregions of the mouseH-2 complex

L. Hood, J. Frelinger, P. Wettstein, 1978, Immunogenetics.

Serological and biochemical characterization of rat (RT1) class II molecules with restricted mouse anti-Ia sera

L. Hood, P. Wettstein, J. Frelinger, 2004, Immunogenetics.

ISOLATION AND CHARACTERIZATION OF cDNA CLONES ENCODING MOUSE TRANSPLANTATION ANTIGENS1

L. Hood, J. Frelinger, M. Steinmetz, 1981 .

Interleukin 3 Enhances Development of T \ imor-reactive Cytotoxic Cells by a CD 4-dependent Mechanism 1 ' 2

Elizabeth, Stephen, J. McAdam, 2006 .

T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes.

J. Frelinger, E. Lord, R. A. Willis, 2001, Journal of immunological methods.

Development of a Novel Methodology for Improving CTL Recognition of Prostate Specific Antigen (PSA) for the Immunotherapy of Prostate Cancer

J. Frelinger, 2001 .

An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis

J. Frelinger, Michael D. Valentino, 2009, Immunologic research.

CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott‐Aldrich fibroblasts via transfection of a leukosialin cDNA

M. Fukuda, J. Frelinger, A. Pallant, 1990, European journal of immunology.

Differential expression of interleukin 1 alpha by Thy-1+ and Thy-1- lung fibroblast subpopulations: enhancement of interleukin 1 alpha production by tumor necrosis factor-alpha.

P. Keng, D. Penney, D. Brown, 1990, European journal of immunology.

Inoculating a New Generation: Immunology in Medical Education

C. Haidaris, J. Frelinger, 2019, Front. Immunol..

Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1α

T. Foster, S. Mitra, D. Niles, 2006, Molecular Cancer Therapeutics.

Activation of Heat Shock Protein 70 Promoter with meso-Tetrahydroxyphenyl Chlorin Photodynamic Therapy Reported by Green Fluorescent Protein In Vitro and In Vivo¶

T. Foster, S. Mitra, J. Frelinger, 2003 .

Activation of Heat Shock Protein 70 Promoter with meso‐Tetrahydroxyphenyl Chlorin Photodynamic Therapy Reported by Green Fluorescent Protein In Vitro and In Vivo ¶

T. Foster, S. Mitra, J. Frelinger, 2003, Photochemistry and photobiology.

Characterization of an IL-12 p40/p35 Truncated Fusion Protein That can Inhibit the Action of IL-12.

J. Frelinger, Denise Skrombolas, Shivana Maharaj, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Identification of T‐cell epitopes in Francisella tularensis using an ordered protein array of serological targets

J. Frelinger, T. Kawula, J. Frelinger, 2011, Immunology.

Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.

J. Frelinger, T. Kawula, J. Frelinger, 2009, Molecular immunology.

Local expression of interleukin‐2 by B16 melanoma cells results in decreased tumour growth and long‐term tumour dormancy

S. Gerber, J. Frelinger, E. Lord, 2013, Immunology.

FUNCTIONAL STUDIES OF IMMUNE RESPONSE UTILIZING MURINE T CELL CLONES

A. Singer, Y. Asano, M. Kimoto, 1982 .

Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival.

R. Barth, J. Frelinger, L. Dragone, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints

K. Odunsi, J. Skitzki, A. Luster, 2015, Nature Communications.